by Geoff Considine The challenge for many investors who are trying to diversify their portfolios is finding sectors or asset classes that don’t move in tandem together. One sector that has moved up—even as many equity indexes have fallen—is biotech. Performance: Behind the Numbers Over the past three months, even as the S&P 500 and other [...]